Thin, flexible, translucent patch applied
twice weekly for continuous delivery of oxybutynin 3.9 mg/day through
the skin
OXYTROL is contraindicated in patients with
urinary retention,
gastric retention, or uncontrolled narrow angle glaucoma and in patients
who are at risk for these conditions. OXYTROL is also contraindicated
in patients who have demonstrated hypersensitivity to oxybutynin
or other components of the product. OXYTROL should be administered
with caution in the following patients: those with hepatic or renal
impairment; clinically significant bladder outflow obstruction;
gastrointestinal obstructive disorders because of the risk of gastric
retention; patients with gastroesophageal reflux.
Please see full prescribing
information for OXYTROL